TransMolecular, Inc.
TransMolecular is a biotechnology company committed to discovering, developing and commercializing novel and proprietary drugs to diagnose and treat human cancers having inadequate pharmaceutical alternatives. The company has built a strong technology platform around targeted therapeutics that bind only to specific cancer cell types. EHCP led a private financing of the company. Other prominent investors included TVM, Tullis-Dickerson & Co., MDS Capital, Dow Pension Fund, Oakwood Medical Investors, Aperture Venture Partners, Global Biomedical Partners and Cogene Biotech Ventures."